ArticleBMC cancer2025

Torso FDG-PET parameters as prognostic biomarkers for advanced non-small cell lung cancer patients undergoing first-line immunotherapy and chemotherapy.

Takafumi Obata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.